Allogeneic Hematopoietic Stem Cell Transplantation Recipient (DBCOND0111479)

Identifiers

Synonyms

Allogeneic Hematopoietic Stem Cell Transplant Recipient / Allogeneic Hematopoietic Stem Cell Recipients

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04160390	Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant	No drug interventions	Not Available	Not Available	recruiting
NCT03023631	Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant	Human papillomavirus type 11 L1 capsid protein antigen Human papillomavirus type 16 L1 capsid protein antigen Human papillomavirus type 18 L1 capsid protein antigen Human papillomavirus type 31 L1 capsid protein antigen Human papillomavirus type 33 L1 capsid protein antigen Human papillomavirus type 45 L1 capsid protein antigen Human papillomavirus type 52 L1 capsid protein antigen Human papillomavirus type 58 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen	prevention	4	active_not_recruiting
NCT01822509	Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant	Ipilimumab Nivolumab	treatment	1	completed
NCT02220985	Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD	Cyclophosphamide Fludarabine Methopterin Methotrexate Mycophenolate mofetil Tacrolimus Thiotepa Tromethamine	treatment	2	active_not_recruiting
NCT04177004	Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant	Beta-D-Glucose Cyclophosphamide Etoposide Palifermin Sirolimus Tacrolimus	supportive_care	1	recruiting
NCT04099082	Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans	No drug interventions	Not Available	Not Available	recruiting
NCT03665675	Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT	Allogeneic cytomegalovirus-specific cytotoxic T lymphocytes	treatment	0	recruiting
NCT03719092	High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant	No drug interventions	prevention	Not Available	recruiting
NCT03600155	Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome	Ipilimumab Nivolumab	treatment	1	active_not_recruiting
NCT03779854	Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant	Busulfan Cyclophosphamide Fludarabine Methopterin Methotrexate Tacrolimus Thiotepa	treatment	2	recruiting
NCT01629511	Allogeneic Stem Cell Transplant for CLL	Aloe vera leaf Antilymphocyte immunoglobulin (horse) Antithymocyte immunoglobulin (rabbit) Ascorbic acid Busulfan Clofarabine Filgrastim Gemcitabine Glycerin Methopterin Methotrexate Nicotinamide Tacrolimus Vitamin A	treatment	1 / 2	terminated
NCT03925532	Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant	Denosumab	supportive_care	2	completed
NCT03851081	Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia	Inotuzumab ozogamicin Vincristine	treatment	1 / 2	withdrawn
NCT02083250	Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant	Aloe vera leaf Antilymphocyte immunoglobulin (horse) Antithymocyte immunoglobulin (rabbit) Ascorbic acid Busulfan Clofarabine Fludarabine Glycerin Nicotinamide Vitamin A Vorinostat	treatment	1	completed